Previous Article | Next Article ![]()
Infection and Immunity, May 2006, p. 3027-3029, Vol. 74, No. 5
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.5.3027-3029.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Pathobiology, University of Washington, Seattle, Washington
Received 27 October 2005/ Returned for modification 21 November 2005/ Accepted 1 February 2006
Previous studies determined that the Chlamydia glycan contains a high-mannose oligosaccharide, which is involved in attachment and infectivity of the organism, and that removal of the glycan decreases infectivity in vitro. The present study demonstrates that treatment of the organism with N-glycanase decreases or ablates infectivity in vivo.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|